Tissue response and clinical outcomes after cardiovascular use of porcine small intestinal small intestinal submucosal extracellular matrix: a systematic review

BackgroundPorcine small intestinal submucosal extracellular matrix (PSIS-ECM) is a biomaterial that has gained increasing popularity in cardiovascular surgery over the past three decades. This popularity is due to PSIS-ECM demonstrating properties of an ideal biological scaffold; it is easy to use,...

Full description

Saved in:
Bibliographic Details
Main Authors: Villads Juul Bruun, Line Lyngbak Jensen, J. Michael Hasenkam, Johannes H. Jedrzejczyk
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-06-01
Series:Frontiers in Cardiovascular Medicine
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fcvm.2025.1532157/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1839655873586135040
author Villads Juul Bruun
Line Lyngbak Jensen
J. Michael Hasenkam
J. Michael Hasenkam
Johannes H. Jedrzejczyk
Johannes H. Jedrzejczyk
author_facet Villads Juul Bruun
Line Lyngbak Jensen
J. Michael Hasenkam
J. Michael Hasenkam
Johannes H. Jedrzejczyk
Johannes H. Jedrzejczyk
author_sort Villads Juul Bruun
collection DOAJ
description BackgroundPorcine small intestinal submucosal extracellular matrix (PSIS-ECM) is a biomaterial that has gained increasing popularity in cardiovascular surgery over the past three decades. This popularity is due to PSIS-ECM demonstrating properties of an ideal biological scaffold; it is easy to use, lacks immunogenicity, is absorbable, possesses the potential to promote native tissue growth, and exhibits remodelling properties. We systematically reviewed the literature on the preclinical and clinical use of this approach in cardiovascular surgery over the past decade.MethodsUtilizing a box-search methodology, an extensive survey of the literature on PSIS-ECM's application in cardiovascular surgery from 2013 until September 2023 was conducted within the PubMed and Embase databases. Initially, 245 publications were identified. Following title, abstract, and full-text screening, 66 articles were included in the survey.ResultsAmong nine preclinical studies conducting histological assessments of explants, eight did not report signs of inflammation. Tissue remodelling was documented in six preclinical studies. Histological examination of explants was incorporated into thirteen clinical cohort studies, all of which demonstrated varying intensities of inflammation and no or minimal signs of regeneration and remodeling. The reintervention rates among clinical cohort studies range from 4.5% to 87.5%. Eleven studies reported a reintervention rate exceeding 15%, while six reported a reintervention rate below 15%.ConclusionPreclinical studies corroborate the notion that PSIS-ECM exhibits properties of an ideal biological scaffold. However, these findings lack reproducibility in clinical settings. Combined with reports from clinical studies showing reintervention rates exceeding 15%, this has raised concerns about whether clinical application of PSIS-ECM should be confined to selected cases.
format Article
id doaj-art-a53daccea61d443c9a8f9731deb1b14d
institution Matheson Library
issn 2297-055X
language English
publishDate 2025-06-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Cardiovascular Medicine
spelling doaj-art-a53daccea61d443c9a8f9731deb1b14d2025-06-25T05:24:24ZengFrontiers Media S.A.Frontiers in Cardiovascular Medicine2297-055X2025-06-011210.3389/fcvm.2025.15321571532157Tissue response and clinical outcomes after cardiovascular use of porcine small intestinal small intestinal submucosal extracellular matrix: a systematic reviewVillads Juul Bruun0Line Lyngbak Jensen1J. Michael Hasenkam2J. Michael Hasenkam3Johannes H. Jedrzejczyk4Johannes H. Jedrzejczyk5Department of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, DenmarkDepartment of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, DenmarkDepartment of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, DenmarkDepartment of Clinical Medicine, Aarhus University, Aarhus, DenmarkDepartment of Cardiothoracic and Vascular Surgery, Aarhus University Hospital, Aarhus, DenmarkDepartment of Clinical Medicine, Aarhus University, Aarhus, DenmarkBackgroundPorcine small intestinal submucosal extracellular matrix (PSIS-ECM) is a biomaterial that has gained increasing popularity in cardiovascular surgery over the past three decades. This popularity is due to PSIS-ECM demonstrating properties of an ideal biological scaffold; it is easy to use, lacks immunogenicity, is absorbable, possesses the potential to promote native tissue growth, and exhibits remodelling properties. We systematically reviewed the literature on the preclinical and clinical use of this approach in cardiovascular surgery over the past decade.MethodsUtilizing a box-search methodology, an extensive survey of the literature on PSIS-ECM's application in cardiovascular surgery from 2013 until September 2023 was conducted within the PubMed and Embase databases. Initially, 245 publications were identified. Following title, abstract, and full-text screening, 66 articles were included in the survey.ResultsAmong nine preclinical studies conducting histological assessments of explants, eight did not report signs of inflammation. Tissue remodelling was documented in six preclinical studies. Histological examination of explants was incorporated into thirteen clinical cohort studies, all of which demonstrated varying intensities of inflammation and no or minimal signs of regeneration and remodeling. The reintervention rates among clinical cohort studies range from 4.5% to 87.5%. Eleven studies reported a reintervention rate exceeding 15%, while six reported a reintervention rate below 15%.ConclusionPreclinical studies corroborate the notion that PSIS-ECM exhibits properties of an ideal biological scaffold. However, these findings lack reproducibility in clinical settings. Combined with reports from clinical studies showing reintervention rates exceeding 15%, this has raised concerns about whether clinical application of PSIS-ECM should be confined to selected cases.https://www.frontiersin.org/articles/10.3389/fcvm.2025.1532157/fullporcine small intestinal submucosal extracellular matrixsmall intestinal submucosal extracellular matrixCorMatrixcardiovascular surgerytissue engineeringbio scaffold
spellingShingle Villads Juul Bruun
Line Lyngbak Jensen
J. Michael Hasenkam
J. Michael Hasenkam
Johannes H. Jedrzejczyk
Johannes H. Jedrzejczyk
Tissue response and clinical outcomes after cardiovascular use of porcine small intestinal small intestinal submucosal extracellular matrix: a systematic review
Frontiers in Cardiovascular Medicine
porcine small intestinal submucosal extracellular matrix
small intestinal submucosal extracellular matrix
CorMatrix
cardiovascular surgery
tissue engineering
bio scaffold
title Tissue response and clinical outcomes after cardiovascular use of porcine small intestinal small intestinal submucosal extracellular matrix: a systematic review
title_full Tissue response and clinical outcomes after cardiovascular use of porcine small intestinal small intestinal submucosal extracellular matrix: a systematic review
title_fullStr Tissue response and clinical outcomes after cardiovascular use of porcine small intestinal small intestinal submucosal extracellular matrix: a systematic review
title_full_unstemmed Tissue response and clinical outcomes after cardiovascular use of porcine small intestinal small intestinal submucosal extracellular matrix: a systematic review
title_short Tissue response and clinical outcomes after cardiovascular use of porcine small intestinal small intestinal submucosal extracellular matrix: a systematic review
title_sort tissue response and clinical outcomes after cardiovascular use of porcine small intestinal small intestinal submucosal extracellular matrix a systematic review
topic porcine small intestinal submucosal extracellular matrix
small intestinal submucosal extracellular matrix
CorMatrix
cardiovascular surgery
tissue engineering
bio scaffold
url https://www.frontiersin.org/articles/10.3389/fcvm.2025.1532157/full
work_keys_str_mv AT villadsjuulbruun tissueresponseandclinicaloutcomesaftercardiovascularuseofporcinesmallintestinalsmallintestinalsubmucosalextracellularmatrixasystematicreview
AT linelyngbakjensen tissueresponseandclinicaloutcomesaftercardiovascularuseofporcinesmallintestinalsmallintestinalsubmucosalextracellularmatrixasystematicreview
AT jmichaelhasenkam tissueresponseandclinicaloutcomesaftercardiovascularuseofporcinesmallintestinalsmallintestinalsubmucosalextracellularmatrixasystematicreview
AT jmichaelhasenkam tissueresponseandclinicaloutcomesaftercardiovascularuseofporcinesmallintestinalsmallintestinalsubmucosalextracellularmatrixasystematicreview
AT johanneshjedrzejczyk tissueresponseandclinicaloutcomesaftercardiovascularuseofporcinesmallintestinalsmallintestinalsubmucosalextracellularmatrixasystematicreview
AT johanneshjedrzejczyk tissueresponseandclinicaloutcomesaftercardiovascularuseofporcinesmallintestinalsmallintestinalsubmucosalextracellularmatrixasystematicreview